Download now the white paper 'Start EU-HTA 2025'. We hope you enjoy reading it!
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essential market access areas covered
This course offers a deep dive into patient involvement in HTA processes across Europe, with a focus on the UK and Germany - learn practical approaches, regulatory insights, and how to engage meaningfully with patient organisations.
This seminar will focus on AMNOG and JCA dossier preparation as well as the German AMNOG procedure in comparison with the EU HTA procedure.
You will gain actionable insights into global market access strategies, payer evidence requirements, and health economic tools - enabling you to support strategic decision-making across diverse healthcare systems.
This online seminar provides a comprehensive introduction to drug market access and pricing strategies in five key European countries: Germany, Spain, the UK, Italy, and France. Designed for beginners and professionals seeking structured insights into HTA systems, stakeholder roles, and pricing negotiations.
